COMPANY

Adaptin Bio

HQ: Charlotte, NC source · adaptinbio.com ↗ · Southeast

Keywords: drug delivery precision medicine

Location: Charlotte, NC · source · Oct 15, 2026

Profile checked Oct 10, 2026

$7.7MRaised (2 yrs)

Funding and NIH signals

SEC Form D raise Raised $1.91M (Form D filed Jan 5, 2026; amended Jun 22, 2026). SEC Form D 0001938571-26-000001 (Jan 5, 2026)
Evidence (1 event)
- Jan 5, 2026 · SEC Form D 0001938571-26-000001
  Name of Issuer: ADAPTIN BIO, INC.; CIK: 1938571; Address: Charlotte, NC; Submission type: D; Filing date: 2026-01-05; Industry Group: Biotechnology; Date of First Sale: 2025-12-22; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 4000000; Total Amount Sold: 1000000; Federal exemptions: 06b || Name of Issuer: ADAPTIN BIO, INC.; CIK: 1938571; Address: Charlotte, NC; Submission type: D/A; Filing date: 2026-02-20; Industry Group: Biotechnology; Date of First Sale: 2025-12-22; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 4000000; Total Amount Sold: 1297000; Federal exemptions: 06b || Name of Issuer: ADAPTIN BIO, INC.; CIK: 1938571; Address: Charlotte, NC; Submission type: D/A; Filing date: 2026-03-23; Industry Group: Biotechnology; Date of First Sale: 2025-12-22; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 4000000; Total Amount Sold: 1652000; Federal exemptions: 06b || Name of Issuer: ADAPTIN BIO, INC.; CIK: 1938571; Address: Charlotte, NC; Submission type: D/A; Filing date: 2026-06-22; Industry Group: Biotechnology; Date of First Sale: 2025-12-22; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 4000000; Total Amount Sold: 1912000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

Apr 7, 2025 Raise Follow-on offering: $7.7M (total, as published), announced Apr 7, 2025. Source: SEC filing. source ↗

Funding

Raised: $7.7M. Last 2 years.

Apr 7, 2025 Follow-on offering: $7.7M (total, as published), announced Apr 7, 2025. Source: SEC filing. source ↗

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

2026-06-22 Raise Private raise, amended notice (SEC Form D/A): $1.9M sold of $4.0M offered; issuer “ADAPTIN BIO, INC.”. Verified from the SEC filing. SEC filing ↗
2026-03-23 Raise Private raise, amended notice (SEC Form D/A): $1.7M sold of $4.0M offered; issuer “ADAPTIN BIO, INC.”. Verified from the SEC filing. SEC filing ↗
2026-02-20 Raise Private raise, amended notice (SEC Form D/A): $1.3M sold of $4.0M offered; issuer “ADAPTIN BIO, INC.”. Verified from the SEC filing. SEC filing ↗
2026-01-05 Raise Private raise (SEC Form D): $1.0M sold of $4.0M offered; issuer “ADAPTIN BIO, INC.”. Verified from the SEC filing. SEC filing ↗
2025-02-26 Raise Private raise (SEC Form D): $13.1M sold of $23.4M offered; issuer “ADAPTIN BIO, INC.”. Verified from the SEC filing. SEC filing ↗